Cosentyx Approved Uses
Cosentyx (secukinumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and hidradenitis suppurativa in adults, including those 65 and older.[1][2] These approvals apply without age-specific exclusions, based on FDA labeling that covers adults broadly.[1]
Safety and Use in Elderly Patients
No unique efficacy data exists for patients 65+, but trials included them with similar response rates to younger adults.[2] Increased infection risk occurs due to age-related immune decline, plus higher chances of diverticulitis, malignancy, and hypersensitivity.[1][3] Monitor closely; no dose adjustments needed solely for age.[2]
How Cosentyx Works for These Conditions
It blocks IL-17A, reducing inflammation in autoimmune skin and joint diseases. In plaque psoriasis, it clears plaques; in arthritis types, it eases pain and stiffness.[1] Elderly patients may see slower skin improvement but comparable joint relief.[3]
Common Side Effects Elderly Patients Report
Upper respiratory infections (most frequent), diarrhea, and injection-site reactions hit harder in older adults.[1] Rare serious risks like tuberculosis reactivation or IBD flares require screening.[2] Patients over 65 report 10-15% higher infection rates in post-marketing data.[3]
Differences from Younger Patients
Efficacy holds, but comorbidities (e.g., heart disease, diabetes) amplify risks. Contraindicated with active infections or IBD history regardless of age.[1] Geriatric studies show no pharmacokinetic changes, but frailty may limit self-injection.[2]
Treatment Timeline and Expectations
Visible skin improvements start at week 4, peak by week 12; arthritis relief in 2-4 weeks.[1] Elderly may need longer for full response due to slower healing.[3]
Alternatives for Elderly
TNF inhibitors like Humira or Enbrel have similar profiles but different infection risks; IL-23 blockers like Tremfya may suit milder cases. Methotrexate combos possible but increase toxicity in seniors.[2][4]
[1]: FDA Cosentyx Label
[2]: Novartis Cosentyx Prescribing Info
[3]: PubMed: Secukinumab in Older Adults
[4]: Drugs.com Cosentyx Alternatives